focus -WSS

focus

author：explore 2025-10-01 02:15:41 - browse：42

Illustration of a doctor and patient. The shadow behind the doctor displays 0s and 1s for artificial intelligence. –– health tech coverage from STAT — Molly Ferguson for STAT

The world’s largest technology companies are racing to build generative AI into every corner of health and medicine.

Microsoft has formed an alliance with the electronic health records vendor Epic to wire the technology into dozens of health software products. Google is infusing it into tools used by hospitals to collect and organize data on millions of patients. Not to be outdone, Amazon has unveiled a service to help build clinical note scribes, and is separately working to embed generative AI in drug research and development.

All of this has unfolded faster than federal regulators could blink — or answer questions about how the technology should be tested and evaluated, whether it will help or hurt patients, and how it will impact privacy and the use of personal data.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

explore

WSS

In the gardens at Boston Children's Hospital, families find sanctuary

Why sickle cell disease is getting the first CRISPR treatment

Democrats decry new health bill for going easy on private equity

'Investigate these claims': UFO transparency at center of House hearing

Biogen says it will cut costs by $700 million, slash 1,000 jobs

New lawsuit accuses health insurer Cigna of denying claims in bulk

explore

focus

hotspot

In Memoriam: Notable people who died in 2023

Pfizer plans to depart BIO

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Pregnancy discrimination could be enabled by AI

At least 13 dead in Texas as scorching temps continue

STAT letters to the editor on burnt

Medicare details structure of new drug price negotiation program

New Alzheimer's drugs heat up race for early detection blood tests

Heart attack and stroke risk calculators need revising

What causes rare myocarditis in young men after Covid vaccines?

hotspot

Dems pitch expanding Medicare power to negotiate drug prices

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Pharma patents targeted by Biden in move to slash drug prices

Patients' immediate access to test results puts radiologists in a bind

Democrats decry new health bill for going easy on private equity

hotspot

explore

explore

entertainment